Filing Flows › BioScience Health Innovations (BHIC) › Q2 2025
BioScience Health Innovations (BHIC) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
BioScience Health Innovations (BHIC) reported revenue of $1.8M for the second quarter 2025 (Q2 2025), +357% from a year earlier and +43% from the quarter before. Operating margin was 26.0%, net earnings $458K (26.0% of revenue).
BioScience Health Innovations, Q2 2025: revenue $1.8M (+358% year over year), operating margin 26.0%, net earnings $458K, operating cash flow $285K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | +43% | +357% |
| Gross profit | $1.1M | +20% | +246% |
| Operating profit | $458K | +7% | +517% |
| Net earnings | $458K | +7% | +517% |
| Operating cash flow | $285K | -13% | +311% |
What changed
Revenue was $1.8M in Q2 2025, up 357% year over year and up 43% from the previous quarter.
Gross margin was 61.1%, down 19.7 points from a year earlier. Operating profit was $458K, a 26.0% margin (up 6.7 points year over year). Of the extra revenue versus a year earlier, 28% reached operating profit, above the 19% margin then. Operating expenses grew 161% against revenue growth of 357%. The fastest-growing cost line was Other operating costs (+542%). Net earnings were $458K, up 517% year over year. The effective tax rate was 0.0%.
Operating cash flow was $285K (up 311% year over year), 62% of net earnings. Working capital and other items used $173K.
Questions
What was BioScience Health Innovations' revenue in the second quarter 2025?
BioScience Health Innovations (BHIC) reported revenue of $1.8M for the second quarter 2025 (Q2 2025), +357% from a year earlier and +43% from the quarter before.
Was BioScience Health Innovations profitable in the second quarter 2025?
Operating profit was $458K (26.0% of revenue) and net earnings $458K.